Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS

OBJECTIVE: To evaluate the efficacy and safety of onabotulinumtoxinA 100 U in noncatheterizing patients with multiple sclerosis (MS) with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO). METHODS: In this randomized, double-blind phase III study, patients received onabotulinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Tullman, Mark, Chartier-Kastler, Emmanuel, Kohan, Alfred, Keppenne, Veronique, Brucker, Benjamin M., Egerdie, Blair, Mandle, Meryl, Nicandro, Jean Paul, Jenkins, Brenda, Denys, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105039/
https://www.ncbi.nlm.nih.gov/pubmed/30030330
http://dx.doi.org/10.1212/WNL.0000000000005991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105039/
https://www.ncbi.nlm.nih.gov/pubmed/30030330
http://dx.doi.org/10.1212/WNL.0000000000005991

Ejemplares similares